IRIS
MORBIDELLI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.865
EU - Europa 9.994
AS - Asia 6.147
SA - Sud America 1.045
AF - Africa 227
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 31.293
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.716
GB - Regno Unito 2.232
CN - Cina 2.011
RU - Federazione Russa 1.780
SG - Singapore 1.740
IE - Irlanda 1.361
IT - Italia 1.184
BR - Brasile 877
VN - Vietnam 863
SE - Svezia 802
UA - Ucraina 796
FR - Francia 635
DE - Germania 520
HK - Hong Kong 498
KR - Corea 326
FI - Finlandia 299
IN - India 212
TR - Turchia 110
CA - Canada 80
NL - Olanda 77
BD - Bangladesh 67
ZA - Sudafrica 65
ES - Italia 62
AR - Argentina 61
PL - Polonia 58
NG - Nigeria 49
IQ - Iraq 47
MX - Messico 45
JP - Giappone 43
AT - Austria 41
BE - Belgio 36
ID - Indonesia 34
CI - Costa d'Avorio 26
PK - Pakistan 24
CL - Cile 23
KE - Kenya 23
EC - Ecuador 21
CO - Colombia 19
UZ - Uzbekistan 17
GR - Grecia 16
IL - Israele 16
SA - Arabia Saudita 14
AZ - Azerbaigian 13
LT - Lituania 13
MA - Marocco 13
CZ - Repubblica Ceca 12
DZ - Algeria 12
JO - Giordania 12
NP - Nepal 12
PH - Filippine 12
VE - Venezuela 12
AU - Australia 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
PY - Paraguay 10
EG - Egitto 9
LB - Libano 9
PE - Perù 9
IR - Iran 8
UY - Uruguay 8
ET - Etiopia 7
RS - Serbia 7
KG - Kirghizistan 6
LU - Lussemburgo 6
OM - Oman 6
PT - Portogallo 6
BO - Bolivia 5
BY - Bielorussia 5
CH - Svizzera 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GE - Georgia 5
RO - Romania 5
AL - Albania 4
EE - Estonia 4
LK - Sri Lanka 4
PA - Panama 4
BH - Bahrain 3
CY - Cipro 3
EU - Europa 3
HR - Croazia 3
KH - Cambogia 3
KZ - Kazakistan 3
MM - Myanmar 3
MY - Malesia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
NO - Norvegia 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
Totale 31.273
Salva come PNG Salva come JPEG
Città #
Southend 1.970
Dallas 1.763
Fairfield 1.659
Dublin 1.336
Ashburn 1.072
Singapore 1.057
Woodbridge 782
Chandler 742
Seattle 668
Jacksonville 647
Wilmington 626
Cambridge 577
Houston 560
Hong Kong 469
Moscow 468
Santa Clara 448
Beijing 418
San Jose 387
Hefei 376
Ann Arbor 342
Seoul 322
Princeton 260
The Dalles 246
Siena 242
Ho Chi Minh City 239
Nanjing 208
Hanoi 197
Los Angeles 161
Council Bluffs 150
Lauterbourg 142
Florence 128
Dong Ket 115
Helsinki 113
San Diego 99
Milan 97
Boardman 96
Fremont 94
New York 93
Columbus 89
San Mateo 85
Buffalo 80
Nanchang 80
Munich 72
São Paulo 62
Tianjin 55
Johannesburg 54
Shenyang 54
Bengaluru 53
Rome 53
Izmir 51
Redondo Beach 49
Warsaw 45
Abuja 44
Pune 44
Da Nang 42
London 40
Changsha 39
Menlo Park 39
Orem 37
Turku 37
Málaga 36
Brussels 35
Chicago 35
Dearborn 35
Kunming 34
Tokyo 34
Frankfurt am Main 32
Haiphong 31
Hebei 31
Nuremberg 30
San Francisco 30
Shanghai 28
Chennai 27
Lappeenranta 27
Abidjan 26
Jinan 26
Vienna 25
Belo Horizonte 24
Guangzhou 24
Messina 24
Amsterdam 23
Rio de Janeiro 23
Brooklyn 22
Denver 22
Norwalk 22
Poplar 21
Stockholm 21
Zhengzhou 21
Falls Church 20
Jiaxing 20
Lancaster 20
Montreal 20
Naples 20
Prato 20
Atlanta 19
Jakarta 19
Toronto 19
Manchester 18
Phoenix 18
Biên Hòa 17
Totale 21.572
Salva come PNG Salva come JPEG
Nome #
Development of novel cyclic peptides as pro-apoptotic agents 384
Studying Nitric Oxide in Endothelial Cells 371
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents 364
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 344
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 307
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 299
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 295
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects 293
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 289
Cross-talk between endogenous H2S and NO accounts for vascular protective activity of the metal-nonoate Zn(PipNONO)Cl 274
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells 270
Neuronal effects of a nickel-piperazine/NO donor complex in rodents 267
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis 263
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 257
Divergent effects of quercetin conjugates on angiogenesis 252
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 251
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 249
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 248
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 247
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 247
Anti-angiogenic effectiveness of the urokinase receptor-derived peptide UPARANT in a model of oxygen induced retinopathy 247
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 245
Anti-hypertensive property of a nickel-piperazine/NO donor in spontaneously hypertensive rats 244
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 244
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 242
Analysis of the role of chemokines in angiogenesis 240
The metal-nonoate Ni(SalPipNONO) inhibits in vitro tumor growth, invasiveness and angiogenesis 240
Biological characterization of nanocomposite hydrogels 238
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 237
Peptides derived from the histidine-proline rich glycoprotein bind copper ions and exhibit anti-angiogenic properties 237
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 232
Activity of "NO-donor" or "NO-mediated" drugs 230
Efficacy of AdipoDren ® in Reducing Interleukin-1-Induced Lymphatic Endothelial Hyperpermeability 229
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 227
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. 227
Cerebral circulation time is prolonged and not correlated with EDSS in multiple sclerosis patients: a study using digital subtracted angiography 225
Impaired Cerebral Perfusion in Multiple Sclerosis: Relevance of Endothelial Factors 225
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 222
Pharmacological modulation of endothelial function during tissue remodeling in physiopathological conditions 222
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling 220
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 218
Pharmacological tools for the study of H2S contribution to angiogenesis 217
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through a5b1 integrin 213
Effect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: in vivo and ex vivo analysis 212
PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis 211
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 208
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 208
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 207
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 205
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 203
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 203
Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. 202
Influence of Circulating Endothelin-1 and Asymmetric Dimethylarginine on Whole Brain Circulation Time in Multiple Sclerosis 202
The impact of microgravity and hypergravity on endothelial cells 202
Role of nitric oxide in the modulation of angiogenesis 201
Differential contribution of bradykinin receptors in angiogenesis 200
The rabbit corneal pocket assay 197
Angiogenesis 196
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 195
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 195
Nitric oxide in tumor angiogenesis 192
Comparison of the Effect of Two Hyaluronic Acid Preparations on Fibroblast and Endothelial Cell Functions Related to Angiogenesis 192
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis 190
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 189
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivativederivative. Effect on the motility of vascular endothelial cells 188
Molecular mechanisms of resistance to anti-angiogenic drugs 188
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 187
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 187
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 186
New tools for the study of cGMP dependent functions: validation in VEGF induced permeability and angiogenesis 185
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 183
In vitro and in vivo models to study chemokine regulation of angiogenesis 181
The corneal pocket assay 181
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 180
Nitric oxide and angiogenesis 180
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 179
Protective effects of novel metal-nonoates on the cellular components of the vascular system 178
Therapeutic Potential of Anti-Angiogenic Multi-Target N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 176
Effect of nir laser therapy by mls‐mis source on fibroblast activation by inflammatory cytokines in relation to wound healing 176
In vitro and in vivo activation of endothelial cells by colony-stimulating factors 174
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting 173
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 173
Characterization of the Safety Profile of Sweet Chestnut Wood Distillate Employed in Agriculture 173
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1H-pyrazolo[3,4-d]pyrimidines 4-Amino Substituted and Their Biological Evaluation 170
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 170
Endothelium as a source and target of H2S to improve its trophism and function 170
Modeled microgravity affects fibroblast functions related to wound healing 169
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 169
Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function 169
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 169
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. 168
Use of Nutraceuticals in Angiogenesis-Dependent Disorders 168
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway 167
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis 167
Polyphenol-based nutraceuticals for the control of angiogenesis: Analysis of the critical issues for human use 167
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability 166
N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and supresses neuroblastoma tumor growth 164
NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins 164
PluS Nanoparticles Loaded with Sorafenib: Synthetic Approach and Their Effects on Endothelial Cells 164
ETB receptors promote proliferation and migration of endothelial cells 163
Totale 21.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021827 0 0 0 0 0 0 0 0 0 311 248 268
2021/20222.270 140 260 123 329 157 68 104 85 103 235 233 433
2022/20232.789 187 240 356 419 247 562 63 203 281 57 102 72
2023/20241.977 74 38 138 154 59 536 665 89 14 43 35 132
2024/20254.063 90 252 324 291 405 182 97 256 337 191 449 1.189
2025/20269.731 858 1.426 1.558 1.135 1.752 397 1.425 299 413 468 0 0
Totale 31.649